The Clinical Research Coordinating Office (CRCO) serves UW Carbone Cancer Center (UWCCC) members and researchers by providing administrative infrastructure and oversight of all clinical and translational research conducted at the UWCCC, with the principal goal to ensure scientifically sound and high quality clinical research across the UWCCC. The CRCO is composed of experienced research staff that provides support for the strategic aspects of identifying, prioritizing and conducting clinical research activities at UWCCC and UW Affiliate Site Network (Wisconsin Oncology Network). These functions are accomplished through its interactions with key research entities (IRB, Pharmaceutical Research Center and Disease Oriented Working Groups/Clinical Research Groups) and the clinical care entities (Clinical Research Unit, UW Hospital and Clinics). The CRCO also provides essential administrative support to UWCCC clinical research committees such as the Protocol Review and Monitoring Committee and Data Safety and Monitoring Committee. The CRCO staff members provide the following services; Protocol review and implementation, which includes protocol identification, protocol review, protocol activation, study closure, and database management Human subjects committee coordination and oversight, which includes protocol activation and continuing annual review tracking Centralized patient tracking Research policy development, coordination and implementation, which is developed and implemented through the Program Manager Committee and the development of standard operating procedures Training coordination and implementation Education and corrective action facilitation Administrative oversight Protocol development and patient case report forms development for Investigator Initiated Trials Data abstraction and final report tables for Investigator Initiated Trials The Faculty Leader for the CRCO is the Associate Director for Clinical Research (Brad Kahl, M.D.), who has extensive experience in the conduct and oversight of clinical research.

Public Health Relevance

The Clinical Research Coordinating Office (CRCO) serves UW Carbone Cancer Center (UWCCC) members and researchers by providing administrative infrastructure and oversight of all clinical and translational research conducted at the UWCCC, with the principal goal to ensure scientifically sound and high quality clinical research across the UWCCC. The CRCO is composed of experienced research staff that provides support for the strategic aspects of identifying, prioritizing and conducting clinical research activities at UWCCC and UW Affiliate Site Network (Wisconsin Oncology Network).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
4P30CA014520-42
Application #
9067941
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2016-04-01
Budget End
2017-03-31
Support Year
42
Fiscal Year
2016
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Wu, Yirong; Fan, Jun; Peissig, Peggy et al. (2018) Quantifying predictive capability of electronic health records for the most harmful breast cancer. Proc SPIE Int Soc Opt Eng 10577:
Fu, Anqi; Oberholtzer, Sydney M; Bagheri-Fam, Stefan et al. (2018) Dynamic expression patterns of Irx3 and Irx5 during germline nest breakdown and primordial follicle formation promote follicle survival in mouse ovaries. PLoS Genet 14:e1007488
Ni, Dalong; Jiang, Dawei; Kutyreff, Christopher J et al. (2018) Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice. Nat Commun 9:5421
Huynh, Mailee; Pak, Chorom; Markovina, Stephanie et al. (2018) Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-?B activity and increases drug resistance in multiple myeloma. J Biol Chem 293:2452-2465
Farrell, Emily; Armstrong, Annie E; Grimes, Adrian C et al. (2018) Transcriptome Analysis of Cardiac Hypertrophic Growth in MYBPC3-Null Mice Suggests Early Responders in Hypertrophic Remodeling. Front Physiol 9:1442
Net, Jose M; Whitman, Gary J; Morris, Elizabteh et al. (2018) Relationships Between Human-Extracted MRI Tumor Phenotypes of Breast Cancer and Clinical Prognostic Indicators Including Receptor Status and Molecular Subtype. Curr Probl Diagn Radiol :
Jiang, Dawei; Ge, Zhilei; Im, Hyung-Jun et al. (2018) DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury. Nat Biomed Eng 2:865-877
Seok, Seung-Hyeon; Ma, Zhi-Xiong; Feltenberger, John B et al. (2018) Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR). J Biol Chem 293:1994-2005
Chapelin, Fanny; Capitini, Christian M; Ahrens, Eric T (2018) Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer. J Immunother Cancer 6:105
Ni, Dalong; Ferreira, Carolina A; Barnhart, Todd E et al. (2018) Magnetic Targeting of Nanotheranostics Enhances Cerenkov Radiation-Induced Photodynamic Therapy. J Am Chem Soc 140:14971-14979

Showing the most recent 10 out of 1528 publications